BICYCLE THERAPEUTICS PLC (BCYC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Collaboration revenue | 2,920 | 9,977 | 2,676 | 9,361 |
| Research and development | 71,029 | 59,058 | 48,265 | 40,059 |
| General and administrative | 18,493 | 21,123 | 18,257 | 15,949 |
| Total operating expenses | 89,522 | 80,181 | 66,522 | 56,008 |
| Loss from operations | -86,602 | -70,204 | -63,846 | -46,647 |
| Gain (loss) on extinguishment of debt | - | - | -954 | - |
| Interest expense | 54 | 51 | 33 | 824 |
| Interest and other income | 7,473 | 8,414 | 10,583 | 7,774 |
| Total other income, net | 7,419 | 8,363 | 9,596 | 6,950 |
| Net loss before income tax provision | -79,183 | -61,841 | -54,250 | -39,697 |
| (benefit from) provision for income taxes | -231 | -1,087 | -3,448 | 115 |
| Net loss | -78,952 | -60,754 | -50,802 | -39,812 |
| Foreign currency translation adjustment | -1,902 | -1,580 | -2,093 | -314 |
| Total comprehensive loss | -80,854 | -62,334 | -52,895 | -40,126 |
| Earnings per share, basic | -1.14 | -0.88 | -0.74 | -0.77 |
| Earnings per share, diluted | -1.14 | -0.88 | -0.74 | -0.77 |
| Weighted average number of shares outstanding, basic | 69,252,009 | 69,196,945 | 68,988,858 | 51,992,034 |
| Weighted average number of shares outstanding, diluted | 69,252,009 | 69,196,945 | 68,988,858 | 51,992,034 |